Get started Log in

HLUN A — H Lundbeck A/S Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Market Cap
DKK36.31bn
Enterprise Value
DKK45.28bn
Revenue
DKK24.63bn

Citi starts Lundbeck with 'neutral' as patent expiries loom
23/01/2023 13:34
Brief: H Lundbeck Appoints Thomas Gibbs As VP, Head of Co In U.S.
12/01/2023 14:06
Brief: Otsuka And Lundbeck Announce U.S. FDA Acceptance And Priority Review Of sNDA For Brexpiprazole For Treatment Of Agitation Associated With Alzheimer's Dementia
07/01/2023 14:45
Pharma, biotech to keep quality high in 2023 - JPM
03/01/2023 11:11
Europe Research Roundup: Argenx, Rolls Royce, Thales
03/01/2023 07:05
U.S. Parkinson's disease incidence far higher than earlier estimates -study
15/12/2022 18:58
Factbox: Roche's drug failure extends long list of Alzheimer's trial setbacks
14/11/2022 13:45
Europe Research Roundup: AO World, Tele2 AB, Unilever
18/10/2022 07:54
Factbox: Eisai-Biogen Alzheimer's drug success follows many failures
28/09/2022 11:16
Danish life science cos to enjoy 'USD bonanza' in 2023 - Nordnet
28/09/2022 09:26
Factbox: Eisai-Biogen Alzheimer's drug success follows many failures
28/09/2022 24:32
CS upbeat on European pharma thanks to low macro exposure
15/09/2022 10:13
Europe Research Roundup: AstraZeneca, Ericsson, Gsk
15/09/2022 08:32
Brief: Otsuka Pharmaceutical And H. Lundbeck Say U.S. FDA Accepted New Drug Application For Aripiprazole Injectable To Treat Adult Schizophrenia And Bipolar I Disorder
13/09/2022 07:27
Europe Research Roundup: Adyen, Prosus, Verbund
19/08/2022 07:59
Lundbeck shares swell on positive results for dementia drug
27/06/2022 08:22